Consumer Non-Durables euglena Co., Ltd. Business Summary
euglena Co., Ltd. engages in the research, development, production and sale of microalgae products. It operates through the Healthcare; and Energy and Environment segments. The Healthcare segment handles the planning and sale of in-house products, food products and cosmetics using algae.The Energy and Environment segment deals with funded research and technology development with a focus on microalgae. It also engages in the development of bio fuel production technology and investment in bio-tech related business. The company was founded by Mitsuru Izumo, Kengo Suzuki and Takuyuki Fukumoto on August 9, 2005 and is headquartered in Tokyo, Japan.
Financial Highlights
Sep 2020
JPY USD Revenue 13,317.31M 123.50M Gross Profit 9,199.98M 85.32M Operating income -1,807.72M -16.76M Income before tax -1,434.22M -13.30M Net income -1,486.68M -13.78M EBITDA -1,088.90M -10.09M Diluted EPS -16.00 -0.14 Dividends Per Share 0 0 Total Assets 15,351.09M 145.46M Total liabilities 5,964.33M 56.51M Total equity 9,376.98M 88.85M Operating cash flow -1,217.47M -11.29M Currency in JPY Currency in USD
Historical Data Sep 2016 Sep 2017 Sep 2018 Sep 2019 Sep 2020 Revenue
11,103.23M
13,886.60M
15,174.58M
13,967.67M
13,317.31M
Gross Profit
8,014.53M
10,082.03M
10,755.49M
9,731.69M
9,199.98M
Operating income
693.95M
950.93M
-1,379.62M
-7,460.14M
-1,807.72M
Income before tax
919.37M
1,205.53M
-1,109.22M
-9,604.98M
-1,434.22M
Net income
673.34M
785.88M
-1,252.19M
-9,798.56M
-1,486.68M
EBITDA
1,014.05M
1,413.03M
-613.67M
-6,503.60M
-1,088.90M
Diluted EPS
8.05
9.38
-14.70
-107.24
-16.00
Dividends Per Share
0
0
0
0
0
Total Assets
15,526.00M
18,858.06M
21,837.61M
17,199.44M
15,351.09M
Total liabilities
2,103.27M
3,202.78M
5,932.78M
6,365.06M
5,964.33M
Total equity
13,407.53M
15,643.36M
15,900.39M
10,826.65M
9,376.98M
Operating cash flow
913.58M
153.75M
-1,238.02M
1,089.39M
-1,217.47M
Sep 2016 Sep 2017 Sep 2018 Sep 2019 Sep 2020 Revenue
99.44M
124.77M
137.37M
126.93M
123.50M
Gross Profit
71.77M
90.59M
97.36M
88.44M
85.32M
Operating income
6.21M
8.54M
-12.48M
-67.79M
-16.76M
Income before tax
8.23M
10.83M
-10.04M
-87.29M
-13.30M
Net income
6.03M
7.06M
-11.33M
-89.04M
-13.78M
EBITDA
9.08M
12.69M
-5.55M
-59.10M
-10.09M
Diluted EPS
0.07
0.08
-0.13
-0.97
-0.14
Dividends Per Share
0
0
0
0
0
Total Assets
153.32M
167.53M
192.25M
159.14M
145.46M
Total liabilities
20.77M
28.45M
52.23M
58.89M
56.51M
Total equity
132.40M
138.97M
139.98M
100.17M
88.85M
Operating cash flow
8.18M
1.38M
-11.20M
9.90M
-11.29M
Valuation Measures
Sep 2020
PER -- ROA -9.13% ROE -14.71% Operating margin -13.57% Profit margin -11.16%
Key executives
President & Representative Director:
Mitsuru Izumo
Executive Officer, Head-Research & Development:
Kengo Suzuki
Manager-Information System:
Shuji Endo
Director, VP & Manager-Corporate Strategy:
Akihiko Nagata
Executive Officer & Head-Sales:
Takuyuki Fukumoto Shareholders
IZUMO MITSURU (13.1%)
Nomura Asset Management Co., Ltd. (2.5%)
The Vanguard Group, Inc. (1.8%)
Nikko Asset Management Co., Ltd. (1.3%)
Daiwa Asset Management Co. Ltd. (1.2%)
BlackRock Fund Advisors (1.1%)
ENEOS Holdings, Inc. (1.0%)
Tokyo Century Corp. (1.0%)
SUZUKI KENGO (0.9%)
Nihon Kolmar Co., Ltd. (0.8%)
Contact Details Website: http://www.euglena.jp Address:
G-BASE Tamachi 2-3/F,
5-29-11 Shiba,
Tokyo,
108-0014,
Japan
Phone:
+81.3.3453.4907
Related Companies
MEJ Inc.
Sports Innovation KK
Euglena Restricted Stock Compensation Plan
Euglena Investment Co. Ltd.
HELLSEN, Inc.
HOOK Inc.
euglena Taketomi Ebi Yoshoku KK
Euglena Art KK
Genequest, Inc.
Plant High Technology Institute KK
Yaeyama Shokusan Co., Ltd.
epauler Co., Ltd.
Art Corp. KK
Chlorella Supply Co., Ltd.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 20 Jan, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close
